HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Doxifluridine

HCID 18343
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
3094-09-5
Standard SMILES
C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O
InChIKey
ZWAOHEXOSAUJHY-ZIYNGMLESA-N
Molecular formula
C9H11FN2O5
Average molar mass
246.19 g/mol
Monoisotopic mass
246.06519962

Overview

Doxifluridine is a pyrimidine 5'-deoxyribonucleoside that is 5-fluorouridine in which the hydroxy group at the 5' position is replaced by a hydrogen. It is an oral prodrug of the antineoplastic agent 5-fluorouracil. Designed to circumvent the rapid degradation of 5-fluorouracil by dihydropyrimidine dehydrogenase in the gut wall, it is converted into 5-fluorouracil in the presence of pyrimidine nucleoside phosphorylase. It has a role as an antimetabolite, an antineoplastic agent and a prodrug. It is an organofluorine compound and a pyrimidine 5'-deoxyribonucleoside.

Names & identifiers

Preferred name
Doxifluridine
IUPAC
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoropyrimidine-2,4-dione
English name
Doxifluridine
Molecular formula
C9H11FN2O5
Molecular weight
246.19

Names & synonyms

doxifluridine5'-Deoxy-5-fluorouridine5-fluoro-5'-deoxyuridineFurtulon3094-09-5Uridine, 5'-deoxy-5-fluoro-Flutron5'-DfurDoxifluridinaDoxifluridinumFulturonRo 219738
Show more names
5'DFURDAMC 01015-F-5‘-dURO-21-97385-cl-5'-dUDoxifluidine
DTXSID2022967Uridine-5'-deoxy-5-fluoro-1-(beta-D-5-Desoxyribofuranoxyl)-5-fluoruracilRo 21-97385-DFURV1JK16Y2JPNSC-758890RO-219738

Database identifiers

CAS
3094-09-5
PubChem CID
18343
DTXSID
DTXSID2022967
ChEMBL
CHEMBL1130
ChEBI
CHEBI:31521
UNII
V1JK16Y2JP
EC Number
221-440-1
Nikkaji
J7.679A

Properties

Computed structural properties

XLogP
-1.7
Topological polar surface area
99.1 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
6
Rotatable bonds
1
Heavy atoms
17
Formal charge
0
Complexity
399

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Antineoplastic and immunomodulating agents -> Antineoplastic agents

Solubility>36.9 [ug/mL] (The mean of the results at pH 7.4)
Collision Cross Section150.41 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
188 · 188-192 °C(lit.)
alpha
25 · D25 +18.4° (c = 0.419 in water)
Density
1.3751 · 1.3751 (estimate)
refractive index
20 ° · 20 ° (C=1, H2O)
storage temp.
Inert atmosphere,Room Temperature
solubility
DMSO (Slightly), Methanol (Slightly)
form
Solid
pka
7.4 · 7.4(at 25℃)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 16.7% (1 of 6) of reports.

Danger

H226 (16.7%): Flammable liquid and vapor [Warning Flammable liquids]

P203, P210, P233, P240, P241, P242, P243, P261, P264, P264+P265, P271, P272, P273, P280, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P317, P318, P319, P321, P332+P317, P333+P317, P337+P317, P362+P364, P370+P378, P391, P403+P233, P403+P235, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 6 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesFlam. Liq. 3 (16.7%)

Toxicology

Drug Induced Liver Injury · 4 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Doxifluridine

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

Safety data

wgk
2
rtecs
YU7526000
hs_code
29349990
Toxicity
LD50 (14 day) in mice or rats (mg/kg): >1000 i.v.: >2000 s.c.; in male, female mice, male, female rats (mg/kg): >5000, >5000, 3471, 3390 orally (Shimizu)
risk_code
36/37/38
Signal word
Warning

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 3 items

Antimetabolites that are useful in cancer chemotherapy.

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.

Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS.

Tissue LocationsKidney
Cellular LocationsCytoplasm
Metabolite PathwaysCapecitabine Action Pathway
Applications · 5 items

DescriptionDoxifluridine is a prodrug derivative of 5-fluorouracil (5-FU). As an antineoplastic it is more potent than 5-FU in the treatment of breast, stomach, colon and rectal cancers.

UsesA prodrug of 5-Flurouridine. A fluorinated pyrimidine nucleoside with cytostatic activity

UsesAn antitumor agent efficient in tumors, cell lines or in fibroblasts tranformed by H-ras or trk oncogenes. A metabolite of Capecitabine

Usesantineoplastic, pyrimidine antimetabolite

Uses5’-Deoxy-5-fluorouridine is a metabolite of the chemotherapeutic agent Capecitabine (C175650). 5’-Deoxy-5-fluorouridine is an antitumor agent efficient in tumors, cell lines or in fibroblasts tranformed by H-ras or trk oncogenes.

Upstream & downstream products

Upstream raw materials

Related reactions

8 records
New reaction record
HRID 1089416 reaction equation
HRID 1089416As reactant
HRID 1358063 reaction equation
HRID 1358063As product
HRID 1358065 reaction equation
HRID 1358065As product
HRID 1358067 reaction equation
HRID 1358067As product
HRID 1719780 reaction equation
HRID 1719780As product
HRID 1759378 reaction equation
HRID 1759378As product
HRID 1759379 reaction equation
HRID 1759379As product
HRID 2091456 reaction equation
HRID 2091456As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
color
White
Merck
14 · 14,3437
Major Application
pharmaceutical small molecule
InChI
InChI=1S/C9H11FN2O5/c1-3-5(13)6(14)8(17-3)12-2-4(10)7(15)11-9(12)16/h2-3,5-6,8,13-14H,1H3,(H,11,15,16)/t3-,5-,6-,8-/m1/s1
InChIKey
ZWAOHEXOSAUJHY-ZIYNGMLESA-N
SMILES
C[C@H]1O[C@@H](N2C=C(F)C(=O)NC2=O)[C@H](O)[C@@H]1O
CAS DataBase Reference
3094 · 3094-09-5(CAS DataBase Reference)
FDA UNII
1 JK16Y2JP · V1JK16Y2JP
NCI Drug Dictionary
doxifluridine
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
317 · H317
Precautionary statements
261 · P261-P272-P280-P302+P352+P333+P313+P363-P501
Hazard Codes
Xi
Risk Statements
36 · 36/37/38
Safety Statements
26 · 26-36-24/25
WGK Germany
2 · 2
RTECS
7526000 · YU7526000
Hazard Note
Irritant
HazardClass
IRRITANT, IRRITANT-HARMFUL
HS Code
29349990 · 29349990
Storage Class
11 · 11 - Combustible Solids
Toxicity
50 · LD50 (14 day) in mice or rats (mg/kg): >1000 i.v.: >2000 s.c.; in male, female mice, male, female rats (mg/kg): >5000, >5000, 3471, 3390 orally (Shimizu)
Symbol(GHS)
GHS07
hazard_code
Xi
hazard_note
Irritant
safety_code
26-36-24/25
hazard_class
IRRITANT, IRRITANT-HARMFUL
Storage Class
11 - Combustible Solids
Hazard statements
H317
Precautionary statements
P261-P272-P280-P302+P352+P333+P313+P363-P501
Palladium carbon fine chemical catalyzerp-Toluenesulfonic acid monohydrateEthyl acetateTriphenylantimonyIodomethane2,2-Dimethoxypropane
Additional notes · 1 item

DefinitionChEBI: A pyrimidine 5'-deoxyribonucleoside that is 5-fluorouridine in which the hydroxy group at the 5' position is replaced by a hydrogen. It is an oral prodrug of the antineoplastic agent 5-fluorouracil. Designed to circumvent the rapid degradation of 5-fluoro racil by dihydropyrimidine dehydrogenase in the gut wall, it is converted into 5-fluorouracil in the presence of pyrimidine nucleoside phosphorylase.